Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Says German Court Finds Thermo-Finnigan s Ion Traps Infringe on Mass Spec Patent

NEW YORK, April 12 – A German court ruled Thursday that Thermo-Finnigan's GCQ and LCQ ion traps infringe upon Bruker Daltonics’ European patent for ion trap mass spectrometry and ordered Thermo-Finnigan to pay Bruker damages and court costs, Bruker said.

Bruker sued Bremen, Germany-based Thermo Finnigan and its affiliates in Dusseldorf District Court for patent infringement of its patent EP 0336 990, which relates to ion trap technology.

Earlier, Thermo-Finnigan had unsuccessfully sought to invalidate this patent in Germany, according to Bruker.

In an official statement released Thursday, Bruker, of Billerica, Mass., said it expected the court to order Thermo-Finnigan and its German affiliates “to cease and desist from offering, distributing, using, or importing any GCQ or LCQ-series ion traps in Germany.”

The amount of Thermo Finnegan’s liability will be determined by the court at a later date.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.